bioAffinity Technologies, Inc.
BIAF
|
$2.82
1.08%
1.06%
220K
|
(0.0% 1d) (43.8% 1m) (53.3% 1y) (0.0% 2d) (0.0% 3d) (1.1% 7d) (9.62% volume)
Earnings Calendar:
Market Cap: $ 32,470,478
Sec Filling | Patents | 2022 employees
addressing a critical need to find cancer early and treat cancer specifically bioaffinity technologies, inc. develops tests and therapies to detect and treat cancer at the cellular level. our first product, cypath® flow cytometry for lung cancer (cypath® lung), has been licensed by precision pathology services for continued development and commercial sale as a laboratory developed test. cypath® lung has the potential to dramatically increase overall diagnostic accuracy leading to increased survival, fewer unnecessary invasive procedures and lower patient anxiety and medical costs.
machine learning respiratory lung cancer diagnostics
add to watch list Paper trade email alert is off
Press-releases
bioAffinity Technologies Expands Campaign to Support American Cancer Society Initiative for Lung Cancer Screening
Published: 2024-04-09 (Crawled : 13:00) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: -7.22%
H: 0.0%
C: -3.33%
lung initiative cancer for
bioAffinity Technologies Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-04-01 (Crawled : 17:00) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: 2.97%
H: 1.92%
C: 0.48%
year financial results
Medical Director of Lung Innovations Network and The Lung Center at Penn Highlands Healthcare, Sandeep Bansal, M.D., Joins bioAffinity Technologies’ Medical and Scientific Advisory Board
Published: 2024-02-06 (Crawled : 13:30) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: -0.38%
H: 0.64%
C: -0.64%
lung network medical
bioAffinity Technologies In The News - January 30, 2024
Published: 2024-01-30 (Crawled : 13:30) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: 2.5%
H: 0.51%
C: -2.44%
bioAffinity Technologies Announces Award of Therapeutic Patent for Treatment of Cancer - January 23, 2024
Published: 2024-01-23 (Crawled : 14:30) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: 5.3%
H: 0.0%
C: -2.52%
award patent cancer treatment
bioAffinity Technologies In the News
Published: 2024-01-08 (Crawled : 14:30) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: 7.22%
H: 0.0%
C: -4.88%
bioAffinity Technologies Teams with American Cancer Society to Raise Funds for Lung Cancer Screening
Published: 2023-11-15 (Crawled : 14:00) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: 0.6%
H: 0.0%
C: -2.39%
lung cancer
bioAffinity Technologies Reports Third Quarter 2023 Financial Results and Provides Business Update
Published: 2023-11-14 (Crawled : 00:00) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: -2.33%
H: 7.14%
C: 2.93%
business update financial results
bioAffinity Technologies Names Dallas J. Coleman as National Director of Sales
Published: 2023-11-06 (Crawled : 14:30) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: 5.49%
H: 0.0%
C: -8.05%
sales
bioAffinity Technologies to Present at the 8th Annual Dawson James Small Cap Growth Conference
Published: 2023-10-10 (Crawled : 13:30) - biospace.com/
BIAF | $2.82 1.08% 1.06% 220K
|
|
| O: 8.33%
H: 0.0%
C: -5.59%
conference growth
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 67% | 33% |
Top 10 Gainers
AGBA | News | $1.26 215.0% 68.25% 130M
|
Finance
EGOX | $0.0515 43.06% 30.1% 330M
|
OLB 4 | $0.33 -14.95% 25.53% 840K
|
Technology Services
NVFY | $2.77 31.28% 23.83% 33M
|
Consumer Durables
ZCMD | $1.87 28.97% 22.46% 31M
|
Commercial Services
RCON | $0.1112 13.01% 21.28% 1.7M
|
Distribution Services
INSG | $3.03 25.21% 20.13% 330K
|
Electronic Technology
GCTK | $0.8191 22.25% 18.2% 190K
|
Manufacturing
WLGS | $0.59 18.0% 17.9% 2.3M
|
ASNS | $0.828 21.75% 17.86% 18K
|
Last 48 Hours Insiders Buying
RXO P 200000 | $19.37 2.32% 0.0% 1M
|
n/a
|
23:00
RKT P 380 | $11.68 1.3% 0.17% 1.9M
|
Finance
|
22:30
HROW P 29400 | $10.43 -3.87% -4.03% 680K
|
Health Technology
|
22:30
BCDA P 2750 | $0.377 -1.4% 97K
|
Health Technology
|
22:00
RMCF | $3.67 3.38% 3.27% 11K
|
Consumer Non-Durables
|
20:10